{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:36:31Z","timestamp":1790562991503,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.tvjl.2013.12.022","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T06:45:11Z","timestamp":1389077111000},"page":"122-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Azithromycin pharmacokinetics in the serum and its distribution to the skin in healthy dogs and dogs with pyoderma"],"prefix":"10.1016","volume":"200","author":[{"given":"Gila","family":"Zur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Soback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yfat","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Lavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malka","family":"Britzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2013.12.022_b0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/31.suppl_E.129","article-title":"Once-daily azithromycin in the treatment of adult skin and skin-structure infections","volume":"31","author":"Amaya-Tapia","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0010","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1128\/AAC.46.5.1594-1596.2002","article-title":"Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients","volume":"46","author":"Blandizzi","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0015","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/AAC.49.6.2372-2377.2005","article-title":"Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin","volume":"49","author":"Bosnar","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/AAC.43.4.813","article-title":"Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs","volume":"43","author":"Breitschwerdt","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0025","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/jac\/dkg003","article-title":"Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers","volume":"50","author":"Chiu","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.tvjl.2013.12.022_b0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/030006059101900602","article-title":"Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group","volume":"19","author":"Daniel","year":"1991","journal-title":"Journal of International Medical Research"},{"key":"10.1016\/j.tvjl.2013.12.022_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2885.2002.00387.x","article-title":"Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes","volume":"25","author":"Davis","year":"2002","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2013.12.022_b0045","doi-asserted-by":"crossref","first-page":"150S","DOI":"10.1592\/phco.2005.25.12part2.150S","article-title":"Infection site concentrations: Their therapeutic importance and the macrolide and macrolide-like class of antibiotics","volume":"25","author":"Drusano","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jac\/21.4.405","article-title":"The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci","volume":"21","author":"Dunkin","year":"1988","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/25.suppl_A.39","article-title":"Comparison of the acid stability of azithromycin and erythromycin A","volume":"25","author":"Fiese","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/31.suppl_E.39","article-title":"Selection of dose regimens of azithromycin","volume":"31","author":"Foulds","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"Foulds","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0070","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.tvjl.2013.12.022_b0075","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/AAC.31.12.1948","article-title":"Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution","volume":"31","author":"Girard","year":"1987","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0215","doi-asserted-by":"crossref","unstructured":"Girard, A.E., Girard, D., Retsema, J.A., 1990. Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection. Journal of Antimicrobial Chemotherapy 25 (Suppl. A), 61\u201371.","DOI":"10.1093\/jac\/25.suppl_A.61"},{"key":"10.1016\/j.tvjl.2013.12.022_b0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/AAC.33.3.277","article-title":"In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: Possible mechanism of delivery and release at sites of infection","volume":"33","author":"Gladue","year":"1989","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0085","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/AAC.34.6.1056","article-title":"Intracellular accumulation of azithromycin by cultured human fibroblasts","volume":"34","author":"Gladue","year":"1990","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.34.3.426","article-title":"Role of protonated and neutral forms of macrolides in binding to ribosomes from Gram-positive and Gram-negative bacteria","volume":"34","author":"Goldman","year":"1990","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2885.1995.tb00549.x","article-title":"Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats","volume":"18","author":"Hunter","year":"1995","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2013.12.022_b0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00003088-199325050-00003","article-title":"Azithromycin clinical pharmacokinetics","volume":"25","author":"Lalak","year":"1993","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.tvjl.2013.12.022_b0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/AAC.00852-06","article-title":"Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen","volume":"51","author":"Liu","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0110","doi-asserted-by":"crossref","first-page":"36S","DOI":"10.1016\/0002-9343(91)90400-R","article-title":"Azithromycin compared with cephalexin in the treatment of skin and skin structure infections","volume":"91","author":"Mallory","year":"1991","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.tvjl.2013.12.022_b0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-3164.2002.00312.x","article-title":"A comparative review of cutaneous pH","volume":"13","author":"Matousek","year":"2002","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2013.12.022_b0120","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/BF01975835","article-title":"Phagocyte uptake and transport of azithromycin","volume":"10","author":"McDonald","year":"1991","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.tvjl.2013.12.022_b0125","series-title":"Muller and Kirk\u2019s Small Animal Dermatology","first-page":"108","article-title":"Dermatologic therapy","author":"Miller","year":"2012"},{"key":"10.1016\/j.tvjl.2013.12.022_b0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ja.2007.10","article-title":"Azalides from azithromycin to new azalide derivatives","volume":"60","author":"Mutak","year":"2007","journal-title":"Journal of Antibiotics"},{"key":"10.1016\/j.tvjl.2013.12.022_b0135","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00006454-199704000-00027","article-title":"Pharmacokinetics and pharmacodynamics of newer macrolides","volume":"16","author":"Nightingale","year":"1997","journal-title":"Pediatrics Infectious Disease Journal"},{"key":"10.1016\/j.tvjl.2013.12.022_b0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-3164.1999.00176.x","article-title":"Macrolides and lincosamides","volume":"10","author":"Noli","year":"1999","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.tvjl.2013.12.022_b0145","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/BF01975831","article-title":"Azithromycin: An antibiotic with unusual properties","volume":"10","author":"Norrby","year":"1991","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.tvjl.2013.12.022_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/31.suppl_E.1","article-title":"In-vitro concentration of azithromycin in human phagocytic cells","volume":"31","author":"Panteix","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0155","first-page":"153","article-title":"Susceptibility to azithromycin of bacteria isolated from infectious processes in dogs and cats","volume":"29","author":"Pereira","year":"2009","journal-title":"Brazilian Journal of Veterinary Research and Animal Science"},{"key":"10.1016\/j.tvjl.2013.12.022_b0160","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1128\/AAC.31.12.1939","article-title":"Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms","volume":"31","author":"Retsema","year":"1987","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/25.suppl_A.83","article-title":"Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo","volume":"25","author":"Retsema","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/31.suppl_E.103","article-title":"A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections","volume":"31","author":"Rodriguez-Solares","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0175","series-title":"Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications","author":"Rowland","year":"2011"},{"key":"10.1016\/j.tvjl.2013.12.022_b0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/25.suppl_A.49","article-title":"Pharmacokinetics of azithromycin in rats and dogs","volume":"25","author":"Shepard","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0185","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2885.2010.01260.x","article-title":"Absorption-dependent apparent volume of distribution at steady state (V(ss)\/F) in pharmacokinetic data analysis","volume":"34","author":"Soback","year":"2011","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2013.12.022_b0190","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1748-5827.2007.00363.x","article-title":"Clinical efficacy and safety of cefovecin in treatment of canine pyoderma and wound infections","volume":"48","author":"Stegemann","year":"2007","journal-title":"Journal of Small Animal Practice"},{"key":"10.1016\/j.tvjl.2013.12.022_b0195","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.42.3.521","article-title":"Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy","volume":"42","author":"Thomas","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jac\/31.suppl_E.51","article-title":"Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine","volume":"31","author":"Wildfeuer","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2013.12.022_b0205","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF01062109","article-title":"Statistical moments in pharmacokinetics","volume":"6","author":"Yamaoka","year":"1978","journal-title":"Journal of Pharmacokinetics and Biopharmaceutics"},{"key":"10.1016\/j.tvjl.2013.12.022_b0210","series-title":"Methods for Pharmacokinetic Analysis for Personal Computer","author":"Yamaoka","year":"1986"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023314000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023314000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T19:01:50Z","timestamp":1565031710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023314000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1090023314000021"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2013.12.022","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azithromycin pharmacokinetics in the serum and its distribution to the skin in healthy dogs and dogs with pyoderma","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2013.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}